Amgen Inc. (AMGN)

Amgen Income Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Revenue	28,190	26,323	25,979	25,424	23,362
Revenue Growth (YoY)	7.09%	1.32%	2.18%	8.83%	-1.62%
Cost of Revenue	8,451	6,406	6,454	6,159	4,356
Gross Profit	19,739	19,917	19,525	19,265	19,006
Selling, General & Admin	6,179	5,414	5,368	5,730	5,150
Research & Development	4,784	4,434	4,819	4,207	4,116
Other Operating Expenses	879	503	1,699	189	66
Operating Expenses	11,842	10,351	11,886	10,126	9,332
Operating Income	7,897	9,566	7,639	9,139	9,674
Interest Expense / Income	2,875	1,406	1,197	1,262	1,289
Other Expense / Income	-2,833	814	-259	-256	-753
Pretax Income	7,855	7,346	6,701	8,133	9,138
Income Tax	1,138	794	808	869	1,296
Net Income	6,717	6,552	5,893	7,264	7,842
Net Income Growth	2.52%	11.18%	-18.87%	-7.37%	-6.58%
Shares Outstanding (Basic)	535	538	570	586	605
Shares Outstanding (Diluted)	538	541	573	590	609
Shares Change	-0.55%	-5.58%	-2.88%	-3.12%	-8.42%
EPS (Basic)	12.56	12.18	10.34	12.40	12.96
EPS (Diluted)	12.49	12.11	10.28	12.31	12.88
EPS Growth	3.14%	17.80%	-16.49%	-4.43%	2.06%
Free Cash Flow	7,359	8,785	8,381	9,889	8,532
Free Cash Flow Per Share	13.76	16.33	14.70	16.88	14.10
Dividend Per Share	8.520	7.760	7.040	6.400	5.800
Dividend Growth	9.79%	10.23%	10.00%	10.34%	9.85%
Gross Margin	70.02%	75.66%	75.16%	75.77%	81.35%
Operating Margin	28.01%	36.34%	29.40%	35.95%	41.41%
Profit Margin	23.83%	24.89%	22.68%	28.57%	33.57%
Free Cash Flow Margin	26.11%	33.37%	32.26%	38.90%	36.52%
Effective Tax Rate	14.49%	10.81%	12.06%	10.68%	14.18%
EBITDA	14,801	12,169	11,296	12,996	12,633
EBITDA Margin	52.50%	46.23%	43.48%	51.12%	54.07%
Depreciation & Amortization	4,071	3,417	3,398	3,601	2,206
EBIT	10,730	8,752	7,898	9,395	10,427
EBIT Margin	38.06%	33.25%	30.40%	36.95%	44.63%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).